Raymond C. Wadlow, MD

Khaled W. Kabbara, MD, and colleagues, research treatment options for cholangiocarcinoma.

Recent improvements in our understanding of the biology of colorectal cancer have led to the identification of several important prognostic and predictive markers of disease-associated risk and treatment response for the individual patient.